Updated PK-Sim Courses (v11)
Updated Courses With MoBi (v11)
With R (v11)
Older Courses Versions (v9 & v10)
OSP-Suite Version 11
Set up an oral administration & formulation protocol and learn how the GI-tract-model mimics absorption, food effect, and CYP3A5 enzymatic clearance process in a population-wide approach.
450,00 €
OSP-Suite Version 11
In this exercise, you learn how to implement kidney disease stages and their impact on pharmacokinetics.
500,00 €
OSP-Suite Version 11
In this series of exercises, you will develop a PBPK model of the sodium/glucose co-transporter 2 inhibitor (SGLT2i) dapagliflozin in pre-clinical species rat, dog, and monkey. You will then translat
500,00 €
OSP-Suite Version 11
In this course, you will learn how to create simulations based on the compounds database of PK-Sim. You will simulate the PK of itraconazole and its metabolite hydroxy-itraconazole, both being substr
500,00 €
OSP-Suite Version 11
In this exercise, you learn how to implement liver disease stages and their impact on pharmacokinetics.
500,00 €
OSP-Suite Version 11
Learn about lipophilicity and partition coefficients, practice sensitivity analysis and parameter identification, and simulate drug clearance with GFR and CYP3A4 involving Michaelis Menten kinetics.
400,00 €
OSP-Suite Version 11
In this exercise you will learn how to set up an (adult model) simulation for morphine PK and compare simulation results to observed data. You will then scale the simulation from adult to 6-year-old
500,00 €
OSP-Suite Version 11
In this exercise, you will learn how to create different types of observers and export them to PK-Sim®.
100,00 €
OSP-Suite Version 11
In this exercise, you will learn how to extend a PBPK model by new compartments and model the distribution of compounds based on partition coefficients. You will implement a simplified model of lysos
150,00 €
OSP-Suite Version 11
In this course, you will learn how to create a PBPK model of Metronidazole, an antibiotic against anaerobic bacteria. You will create• a non-pregnant individual• a non-pregnant population• a pregnant
500,00 €
OSP-Suite Version 11
You will learn how to set up a simulation for large molecules (proteins and peptides) in PK-Sim. The modeled compound is an antibody-drug conjugate (ADC) applied for the treatment of prostate cancer.
1.200,00 €
OSP-Suite Version 11
In this course, you will start with a new MoBi file from scratch. You will create two physical containers connected by a neighborhood. In those containers, two molecules will be transferred from one
150,00 €
OSP-Suite Version 11
You will learn to apply different equation types (Explicit, Sum, Conditional). We will exemplarily assume a simplified circadian clearance of the antiviral medication aciclovir.
100,00 €
OSP-Suite Version 11
Caffeine is the most widely consumed psychoactive or central nervous system (CNS) stimulant in the world. In this course, its dermal application on the chest will be investigated and the impact of hair in absorption is shown.
500,00 €
OSP-Suite Version 11
In this course, you will become familiar with the OSP mechanistic particle dissolution model based on particle size distribution (PSD) and how to parameterize it according to in vitro PSD and dissolu
250,00 €
OSP-Suite Version 11
This training explains the concept of virtual bioequivalence (vBE) analysis and important concepts in the field. You will learn how to set up a VBE workflow for a compound with two formulations.
The
400,00 €
OSP-Suite Version 10
In this course, you will learn how to create simulations based on the compounds database of PK-Sim. You will simulate the PK of itraconazole and its metabolite hydroxy-itraconazole, both being substr
430,00 €
OSP-Suite Version 10
Caffeine is the most widely consumed psychoactive or central nervous system (CNS) stimulant in the world. In this course, its dermal application on the chest will be investigated and the impact of hair in absorption is shown.
430,00 €
OSP-Suite Version 9
In this course, you will start with a new MoBi file from scratch. You will create two physical containers connected by a neighborhood. In those containers, two molecules will be transferred from one
130,00 €
OSP-Suite Version 9
Learn about lipophilicity and partition coefficients, practice sensitivity analysis and parameter identification, and simulate drug clearance with GFR and CYP3A4 involving Michaelis Menten kinetics.
340,00 €
OSP-Suite Version 10
In this exercise, you will learn how to create different types of observers and export them to PK-Sim®.
80,00 €
OSP-Suite Version 10
In this exercise, you will learn how to extend a PBPK model by new compartments and model the distribution of compounds based on partition coefficients. You will implement a simplified model of lysos
130,00 €
OSP-Suite Version 10
In this exercise, you learn how to implement liver disease stages and their impact on pharmacokinetics.
430,00 €
OSP-Suite Version 10
In this series of exercises, you will develop a PBPK model of the sodium/glucose co-transporter 2 inhibitor (SGLT2i) dapagliflozin in pre-clinical species rat, dog, and monkey. You will then translat
430,00 €
OSP-Suite Version 10
You will learn how to set up a simulation for large molecules (proteins and peptides) in PK-Sim. The modeled compound is an antibody-drug conjugate (ADC) applied for the treatment of prostate cancer.
1.020,00 €
OSP-Suite Version 9
Caffeine is the most widely consumed psychoactive or central nervous system (CNS) stimulant in the world. In this course, its dermal application on the chest will be investigated and the impact of hair in absorption is shown.
430,00 €
OSP-Suite Version 9
In this series of exercises, you will develop a PBPK model of the sodium/glucose co-transporter 2 inhibitor (SGLT2i) dapagliflozin in pre-clinical species rat, dog, and monkey. You will then translat
430,00 €
OSP-Suite Version 9
Set up an oral administration & formulation protocol and learn how the GI-tract-model mimics absorption, food effect, and CYP3A5 enzymatic clearance process in a population-wide approach.
380,00 €
OSP-Suite Version 9
In this exercise, you will learn how to extend a PBPK model by new compartments and model the distribution of compounds based on partition coefficients. You will implement a simplified model of lysos
130,00 €
OSP-Suite Version 9
You will learn how to set up a simulation for large molecules (proteins and peptides) in PK-Sim. The modeled compound is an antibody-drug conjugate (ADC) applied for the treatment of prostate cancer.
1.020,00 €
OSP-Suite Version 9
You will learn to apply different equation types (Explicit, Sum, Conditional). We will exemplarily assume a simplified circadian clearance of the antiviral medication aciclovir.
85,00 €
OSP-Suite Version 10
Learn about lipophilicity and partition coefficients, practice sensitivity analysis and parameter identification, and simulate drug clearance with GFR and CYP3A4 involving Michaelis Menten kinetics.
340,00 €
OSP-Suite Version 10
In this course, you will learn how to create a PBPK model of Metronidazole, an antibiotic against anaerobic bacteria. You will create• a non-pregnant individual• a non-pregnant population• a pregnant
430,00 €
OSP-Suite Version 10
You will learn to apply different equation types (Explicit, Sum, Conditional). We will exemplarily assume a simplified circadian clearance of the antiviral medication aciclovir.
80,00 €
OSP-Suite Version 10
Set up an oral administration & formulation protocol and learn how the GI-tract-model mimics absorption, food effect, and CYP3A5 enzymatic clearance process in a population-wide approach.
380,00 €
OSP-Suite Version 10
In this exercise, you learn how to implement kidney disease stages and their impact on pharmacokinetics.
430,00 €
OSP-Suite Version 10
In this exercise you will learn how to set up an (adult model) simulation for morphine PK and compare simulation results to observed data. You will then scale the simulation from adult to 6-year-old
430,00 €
OSP-Suite Version 9
In this exercise, you will learn how to create different types of observers and export them to PK-Sim®.
85,00 €
OSP-Suite Version 9
In this course, you will learn how to create a PBPK model of Metronidazole, an antibiotic against anaerobic bacteria. You will create• a non-pregnant individual• a non-pregnant population• a pregnant
430,00 €
OSP-Suite Version 9
In this exercise you will learn how to set up an (adult model) simulation for morphine PK and compare simulation results to observed data. You will then scale the simulation from adult to 6-year-old
430,00 €
OSP-Suite Version 9
In this course, you will learn how to create simulations based on the compounds database of PK-Sim. You will simulate the PK of itraconazole and its metabolite hydroxy-itraconazole, both being substr
430,00 €